✦ LIBER ✦

Use of anti-tumor necrosis factor agents: A possible therapy for vitiligo

✍ Scribed by Yajie Lv; Qiang Li; Lei Wang; Tianwen Gao

Book ID: 116744804
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 102 KB
Volume: 72
Category: Article
ISSN: 0306-9877
DOI: 10.1016/j.mehy.2008.12.033

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Perioperative use of anti–tumor necrosis

Perioperative use of anti–tumor necrosis factor-alfa agents

✍ Amy Reinstadler; Nicole Mau; Tina Bhutani; Brenna Talkin; Paul Yamauchi; Melvin 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Thrombocytopenia associated with the use

Thrombocytopenia associated with the use of anti–tumor necrosis factor–α agents for psoriasis

✍ Alexandra Maria Giovanna Brunasso; Cesare Massone 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 171 KB

Is there a need for immunopharmacologic

Is there a need for immunopharmacologic guidance of anti–tumor necrosis factor therapies?

✍ Klaus Bendtzen 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 1 views

Pulmonary Adverse Events of Anti-Tumor N

Pulmonary Adverse Events of Anti-Tumor Necrosis Factor-α Antibody Therapy

✍ Gökhan M. Mutlu; Ece A. Mutlu; Amy Bellmeyer; Israel Rubinstein 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 181 KB

Use of anti-tumour necrosis factor agent

Use of anti-tumour necrosis factor agents in inflammatory bowel disease

✍ S. Schreiber; M. Campieri; J.F. Colombel; S.J.H. van Deventer; B. Feagan; R. Fed 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 54 KB

Selective improvement of tumor necrosis

Selective improvement of tumor necrosis factor capture in a cytokine hemoadsorption device using immobilized anti-tumor necrosis factor

✍ Morgan V. DiLeo; James D. Fisher; Brianne M. Burton; William J. Federspiel 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 234 KB

## Abstract Sepsis is a harmful hyper‐inflammatory state characterized by overproduction of cytokines. Removal of these cytokines using an extracorporeal device is a potential therapy for sepsis. We are developing a cytokine adsorption device (CAD) filled with porous polymer beads which efficiently